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ABSTRACT
Purpose: Loss of Retinal Pigment Epithelial (RPE) cells and photoreceptors leads to
Age-related macular degeneration (AMD), one of the leading causes of blindness in the
elderly worldwide. Oxidative stress-mediated damage is one of the factors that impair
the survival of RPE and photoreceptors in dry-AMD. We sought to determine the role of
human Glutathione S-Transferase Mu-1 (GSTM1) in protecting RPE cells from oxidative
stress-induced changes.
Method: We cloned human GSTM1 cDNA with P2A tag into a lenti-plasmid vector and
later made a lentivector to express GSTM1. After that, we infected human retinal
pigment epithelial cells (ARPE-19), screened stable ARPE-19 cells expressing GSTM1
with supplementation of Puromycin antibiotic in the media, and performed western
blotting to check GSTM1 expression in stable cells. The oxidative stress was induced by
H2O2 on stable and control ARPE-19 cells and MTT assay and flow cytometry was
employed to study cell viability. Real-time PCR (RT-PCR) was used to measure
changes in the expression of other antioxidant genes in response to GSTM1 gene
augmentation. For immunocytochemical analysis, we stained differentiated RPE cells
with ZO1 junctional protein and fluorescence images were analyzed to evaluate the
cellular integrity.
Results: The western blotting with GSTM1 antibody confirmed the expression of
exogenous GSTM-1 protein and further affirmed by P2A antibody. The MTT (n=6) and
v

flow cytometry assay (n=3) demonstrated significant cell viability compared to the
control cells (p< 0.05) in response to H2O2 (200μM and 500μM) induced oxidative
stress. The RPE junctional integrity was maintained in the GSTM1 expressing
differentiated cells as compared to the controls. RT-PCR analysis demonstrated
moderate induction in the expression of cytoprotective genes.
Conclusion: GSTM1 gene augmentation in RPE cells can protect against oxidative
stress-mediated changes. Our research opens an avenue for a potential gene therapy
strategy to reverse oxidative stress-mediated changes, thus preventing RPE cell death
associated with progressive vision loss in Dry-AMD.

vi

CHAPTER ONE:
INTRODUCTION

1.1 AMD Statistics
Visual impairment is one of the major health problems that affect millions of people
worldwide. In 2015, it was estimated that 253 million people were affected with visual
impairment globally out of which 36 million were blind, 216.6 million were affected by
moderate to severe visual impairment, 188.5 million showed mild visual impairment
defects. It is predicted to observe a steep increase in the number of cases of visual
impairment in the upcoming years majorly due to the rapid ageing population (Bourne et
al., 2017). Age related macular degeneration (AMD) is a progressive irreversible
blinding disease that affects the central part of the retina known as the macula,
generally in an older population. Even though the macula, which is a pigmented part of
the retina with a diameter of 5.5 mm (Kumar & Tiwari) and comprises of 4% of the total
retinal area, it is responsible for our central and photopic vision (Gehrs et al., 2006).
After cataract and glaucoma, age related macular degeneration is the third cause of
blindness that affects 170 million individuals globally (Hawkins et al., 1999). It is
estimated that AMD accounts for 8.7% of the total blindness worldwide (Arabi et al.,
2017). It is the leading cause of blindness in older populations in the age group of 65
years and above (Quillen, 1999). Based on the literature, the prevalence of AMD in the
United States alone was recorded to affect approximately 11 million individuals.
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(Pennington & DeAngelis, 2016). According to the survey conducted by The Australian
National Eye Health AMD is a prominent reason for vision loss in the non-indigenous
Australian population (Keel et al., 2017). AMD ranked as the thirds cause after cataract
and diabetic retinopathy to cause visual impairments in the regions of central Iran
(Katibeh et al., 2015). The overall burden of AMD in Indian population was in the range
of 1.4% to 3.1%. The rural population demonstrated to be more susceptible as
compared to the urban population which could be associated with the socioeconomic
factors present in the India (Likhar et al., 2015). A population-based study conducted in
an urbane setting of China reported 9.5% of prevalence in age group of 50 years and
older (Ye et al., 2014). In republic of Ireland, AMD accounted for the first cause of
blindness in the age group of 80 years and above (Munier et al., 1998). After a
systematic literature review, the findings indicate that the increasing prevalence of agerelated macular degeneration could prove to be an emerging challenge for the health
care professionals.

1.2 Hallmark of AMD Pathophysiology
The hallmark features of AMD, a sight- threatening disease, are the formation of
drusen and the changes associated with the RPE. Around 1855, a Dutch
ophthalmologist and professor Franciscus Donders first described drusen as
“Colloidkugen” which was later termed as Drusen (Donders, 1855). The German based
word Drusen means ‘node’ or ‘geode’ based on its appearance (Müller, 1856). In 1937,
Verhoeff and Grossman correlated the development of drusen and impairment of
choroidal blood vessels to the pathophysiology associated with AMD (Verhoeff &
2

Grossman, 1937). In AMD the primary lesion is located in the RPE layer which is
possibly due to the higher rate of molecular degradation (Young, 1987). Based on the
Age‐Related Eye Disease Study (AREDS) categorization Category 1 consists of no
drusen or a few small drusen < 63 μm (no AMD). The Category 2 is identified if there
are several small drusen or medium sized drusen 63–124 μm in either or both eyes
(early AMD). The Category 3 consists of many medium sized drusen or one or more
large drusen ≥125 μm in one or both eyes (Intermediate AMD). The Category 4 is
characterized by features like geographic atrophy, atrophy of RPE, Light sensitive cells,
choroidal neovascularization that is an abnormal presence of blood vessels in subretinal space (neovascular AMD) which is an advance form of AMD. As the disease
condition progresses through early AMD to late AMD the damage becomes irreversible
(Farazdaghi & Ebrahimi, 2019; Seddon et al., 2006).

1.3 Classification of AMD
There are two forms of AMD: dry or atrophic AMD which is commonly present in
almost 85-90% of the patients and wet or neovascular AMD occurs in 10-15% of the
patients (Bhutto & Lutty, 2012). Currently treatment options are available for wet AMD
but not for dry AMD.
1.3.1 DRY AMD
The term dry AMD holistically involves the presence of drusen, pigmentary
changes to patchy areas, geographic atrophy (Ferris III et al., 2013). As compared to
the neovascular AMD which is characterized by the presence of choroidal
neovascularization (CNV) the dry AMD is a non-neovascular form (Bandello et al.,
3

2017). Several factors can be linked with the pathophysiology of dry AMD such as age,
immune system changes, race, genetic variations, diet, environmental change, oxidative
stress, the complement system activation and inflammation, lipofuscin accumulation
leading to drusen formation, structural changes in RPE (Ambati & Fowler, 2012).
Drusen formation is associated with the dysfunction of RPE as it conducts various
functions like supplying nourishment to photoreceptors cells, phagocytosis of
photoreceptor debris, and aid in wound healing. The functionality of RPE is
compromised due to the hypoperfusion of choroidal vasculature as it lacks
autoregulation. Due to the aforementioned factors the relationship between RPE,
Bruch’s membrane, and choriocapillaris are disrupted which leads to the development
of drusen and abnormalities of RPE (Bhutto & Lutty, 2012). Clinically, drusen are focal
deposits that are whitish to yellow in coloration deposited beneath the basal membrane
of RPE and Bruch’s membrane (Spaide & Curcio, 2010). The compositional studies of
drusen have revealed that principally it consists of lipid such as cholesterol,
phosphatidyl cholesterol, and unesterified cholesterol derivatives (Haimovici et al.,
2001; Pauleikhoff et al., 1992). A vast number of studies have also indicated the
presence of various proteins such as apolipoproteins E and B (Anderson et al., 2001;
Malek et al., 2003), factors of the complement system, carbohydrates (Mullins &
Hageman, 1999), metals like zinc (Lengyel et al., 2007). They can be categorized as
hard variety and soft variety. Typically, hard drusen are discrete round yellowish-white
spots present commonly in populations. They are not associated with any risk for the
development of neovascularization. In contrast to this soft, non-discrete, confluent, and
with ill- defined margins or placoid/dome shaped structures have a higher prevalence to
4

develop advance forms of AMD (A. Gheorghe et al., 2015). The studies have
demonstrated a link between the inflammation caused due to the oxidative stress and
development of dry AMD (Gass, 1997; Rickman et al., 2013). The presence of NLRP3
inflammasome in RPE cells is associated with the enzyme DICER1. The deficiency of
microRNA- processing enzyme DICER1generally observed in geographic atrophy
patients results in an increase in the Alu RNA in the RPE cells. This consequently
activates NLRP3 inflammasome leading to the death of RPE cells (Tarallo et al., 2012).
For clinical diagnosis of AMD various imaging, measuring and evaluation techniques
are used.
1.3.2 WET AMD
The characteristic feature of wet AMD is the presence of choroidal
neovascularization. Choroidal neovascularization can be defined as the ingrowth of new
blood vessels which originates from choriocapillaris and continues to grow through
Bruch’s membrane into sub-retinal spaces (Campochiaro et al., 1999). As a
consequence of this there is an accumulation of serum or blood or both under RPE.
This condition is referred to as pigment epithelial detachment (PED) leading RPE to
become incompetent to function. PED can be caused due to by serous fluid,
hemorrhagic and fibrovascular tissue (Holz et al., 2001). A common complaint of
patients suffering from CNV is metamorphopsia. This happens due to the accumulation
of serous fluid or blood in the subretinal space which results in an irregular retinal
surface as it causes straight lines in the retina to appear crooked (Bressler et al., 1996).
The clinical manifestations of wet AMD include presence of the fluid in retinal,
subretinal, sub-RPE regions, discoloration, hemorrhage, RPE tear and detachment. The
5

formation of disciform scar (atrophic macular scar) is the end stage of the disease and
leads to permanent damage to central vision (Andreea Gheorghe et al., 2015) (Figure
1). Depending upon the growth patterns: type 1 CNV grows between RPE and Bruch’s
membrane, type 2 between retina and RPE and type 3 is combined pattern. The
balance between the process of angiogenesis promoters and inhibitors is disrupted. In
the initial stages of the disease there is production of VEGF, monocyte colonization
proteins (MCP) and IL8. The macrophages which are attracted towards the outer
surface of the Bruch membrane through the choriocapillaris are known to express tumor
necrosis factor (TNF α) which initiates the stimulation of IL8, MCP, and VEGF
production in the RPE. Accompanied to this, there is expression of integrins α3 and α5
activating the tyrosine kinase signal transduction pathway. In response to VEGF the
vascular endothelium derived from choriocapillaris migrates and proliferates
(Grossniklaus & Green, 2004).

A

B

Figure 1. A Demonstrates normal vision in comparison to the B. affected central
vision in the AMD patients.
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1.4 Glutathione-S-Transferase
1.4.1 Role in cellular detoxification
In the year 1961, the complex enzyme family of glutathione S-transferase (GST)
in animals was first hypothesized to play a role in the metabolism and the detoxification
process of the drugs (Booth et al., 1961) (Figure 2). Over the years their function in the
drug resistance pathways, mediators to ameliorate oxidative stress, facilitating
intracellular transport of environmental carcinogens, and assisting in the prostaglandin
synthesis has been established. In literature, the main focus of study for GST centers
around the overexpression of GSTs in the tumor cell environment leading to the
development of drug resistance to the anti-cancer drugs. The GSTs are ubiquitously
present in the prokaryotic as well as eukaryotic systems. Every day humans are
exposed to a wide range naturally occurring chemicals as well as man-made toxic
compounds. The ability to survive is due to the implementation of strategies like
catalytic biotransformation, scavenging, sequestering of the exposed xenobiotics. This
process of detoxification occurs in three phases. Phase I involves the cytochrome P450
system which plays role in a range of reactions like oxidation, reduction, and
hydroxylation. Phase II involves conjugation of activated xenobiotics with the substrates
like UDP-glucuronic acid, glutathione or glycine in the presence of Phase II enzymes.
These two phases contribute to transforming the water insoluble, non-polar, lipophilic
metabolite into the less toxic and water-soluble compound. Phase III involves pumping
the hydrophilic xenobiotic out of the cell through active transmembrane ATPase such as
the GS-X pump. GSTs play a role in phase II metabolism by catalyzing nucleophilic
aromatic substitutions (Matic et al., 2013).
7

1.4.2 Polymorphism of Glutathione S-Transferase
The family of GSTs comprises of enzymes isoforms Glutathione S-Transferase
(α-Alpha) GSTA1, (μ-Mu) GSTM1, (π-Pi) GSTP1, and (θ-Theta) GSTT1 based on the
substrate specificity and affinity, chemical structure, and kinetic profile of the enzyme.
However, there is 60% similarity within the class of GSTs (Landi, 2000). The common
features in all the polymorphisms include the peroxidase activity which acts against the
generated free radicals and contributes to cellular defenses (Hayes & Strange, 2000). In
the ophthalmic disease conditions one of the major factors being generation of the
oxidative radicals, the eye must inherit protective systems such as superoxide
dismutase (SOD), catalase, glutathione peroxidase (GPx) and glutathione Stransferase. In literature, a process that leads to protein S-thiolation giving rise to a
cascade of events leading to the GST enzyme deactivation, by alteration of protein
conformation leading to protein altercation and aggregation, may result in damage to
the lens which can result in loss of vision. It is demonstrated that exposure to agents
like hydrogen peroxide (H2O2) and hydroquinone (HQ) results in the massive generation
of reactive oxygen species leading to the oxidation of polyunsaturated fatty acid
(PUFA). This produces abundant lipid peroxidation products (LPO) resulting in damage
to the lipid membrane proteins, which has been implicated in macular degeneration
diseases. The antioxidant class of enzymes, GSTs, are involved in the detoxification
process of the LPO (Girotti, 1998).

8

Figure 2. Activity of Glutathione (GSH) on the xenobiotic (X) catalyzed by
Glutathione-S-Transferase (GST) in cellular detoxification process.

1.4.3 Implication of Glutathione S-Transferase in AMD
According to a study, homozygous deletion of GSTM1 and GSTT1 resulting in null
genotypes which results in the loss of enzyme activity is linked with increased risk to
ophthalmologic problems (Karam et al., 2012). A study conducted to link the effect of
cigarette smoking in males and females to the development of cataracts was increased
due to the presence of a null genotype of GSTM1. The frequency of the GSTM1 null
genotype was more (56.9%) as compared to the control non-smokers (40.9%) (Çelįk et
al., 2015). An epigenetic study conducted in the postmortem samples of AMD patients
versus age-matched controls revealed that the mRNA levels of GSTM1 and GSTM5
were significantly lowered due to DNA methylation in RPE/choroid and neurosensory
retina (NSR) (Hunter et al., 2012). Daily supplementation of xaliproden, a 5-OH9

tryptamine (5HT-1) receptor agonist, resulted in a 3.5-fold increase in the expression of
GSTM-1 in a mouse model of geographic atrophy suggesting the protective effect of
GSTM-1 in AMD (Ahmed et al., 2016). Similarly, a 3-fold increase in the expression of
the antioxidant gene GSTM-1 was observed upon daily administration of zeaxanthin, a
carotenoid, to a Sod2flox/flox-VMD2-cre mice model for four months (Biswal et al.,
2018).
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CHAPTER TWO:
MATERIALS AND METHODS
2.1 Materials
2.1.1 General Reagents
The human cDNA sequence for the gene GSTM1 was obtained from the NCBI
database. The GSTM1 plasmid was custom ordered in a pUC vector enclosed in
EcoRV sites from Genescript (Piscataway, NJ). For amplification of pUC GSTM-1,
Phusion Flash High Fidelity PCR Mastermix (F548S) was ordered from Thermo Fisher
scientific, (Waltham, MA). The restriction digestion enzymes used include EcoR I
(FD0274), Not I (FD0593), Xba I(FD0684), Mlu I (FD0564), and Xho I (FD0694). For TR
screening Xma I (R0180S) was obtained from New England Biolabs. For Plasmid
cloning, Invitrogen PureLink Quick Gel Extraction Kit (K210012), Thermo Fisher
Scientific, PureLink HiPure Plasmid Maxiprep kit (K210007), the GeneJet Miniprep kit
(K0503), Rapid DNA Ligation kit (K1422) were utilized. DH5α competent cells (EC0112)
Thermo Fisher Scientific (Waltham, MA) and One Shot Stbl3 chemically competent E.
coli cells (C737303) were purchased from Thermo Fisher Scientific. Transfection grade
Polyethyleneimine (PEI) was from Polysciences (23966-1, Warrington, PA), LGlutamine (G8540). For gel electrophoresis, Agarose LE (UNI-R10113) was ordered
from Unisciences.
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2.1.2 Cell Culture
ARPE-19 cells by ATCC (CRL-2302, Lot Number 7022669; Manassas, VA),
HEK293 cells by ATCC (CRL-157). For cell culture, Dulbecco's Modified Eagle's
Nutrient Mixture F-12(D6421), Dulbecco's Modified Eagle's Nutrient Mixture F-12 color
less media for MTT assay (D6434) Dulbecco's Modified Eagle's Medium (11995-065),
Gibco Opti-mem (31985-070), Trypsin-EDTA Solution (SLCC7775), Fetal Bovine Serum
(F0926), Antibiotic/ Actinomycotic Solution 100X was ordered through Hyclone
(SV30079.01). LB Broth (Miller) Powder microbial growth medium (L3522, Lot Number
MKCJ0452) and LB Broth with Agar (L2897) was ordered through Sigma Life sciences,
Polybrene Viral transfection agent by Millipore Sigma (TR-1003-G), PEG-itTM Virus
Precipitation Solution (5×) (LV810A-1), Puromycin dihydrochloride from Streptomyces
alboniger (P883) from Sigma was used for stable cell selection.

2.1.3 Western Blot
For protein extraction RIPA buffer was prepared following Cold Spring Harbor
Protocols, 1% Protease Inhibitor was ordered from Sigma, Millipore. For protein
quantification, Pierce 660 nm Protein Assay Reagent (22660, Lot Number UA277054)
and Albumin standard (2mg/ml) (23210, Lot Number UE284604) were used. For
validation of Lenti-GSTM-1, the GSTM-1 Polyclonal primary antibody (PA5-22278, Lot
Number UL2901216) and Anti-2A peptide antibody, clone 3H4 (MABS2005) was
purchased from Millipore Sigma. To check the specificity of ARPE-19 cells RPE65
(ab13826) was ordered from Abcam and beta-Actin (84575) was ordered from Cell
Signaling Technology. The secondary antibodies IRDye® 800CW Goat anti-mouse Ig
12

(926-32210) and the IRDye® 680RD Donkey anti-Rabbit IgG Secondary Antibody (92668073) were utilized. 4X Protein Sample loading Buffer (928-40004), iBlot 2 NC Mini
stacks (IB23002), Invitrogen Blot 4-12% Bis-Tris Plus (NW0410BOX), Odessy Blocking
Buffer (TBS) was purchased by LI-COR (927-40000), Blot MEM SDS Running Buffer
(20X) (B0002), Tween 20 (P1379) by Sigma Life Sciences, Precision Protein ladder was
provided by Bio-Rad (161-0374). For immunocytochemistry, primary ZO-1 (402200)
was ordered from Invitrogen and P-mTOR from cell signaling (2976S) were ordered.
The secondary antibody Goat-antirabbit DyLight 594 (DL-1594) was ordered from
vector lab.

2.1.4 Cell Viability
For the process of assessing cell viability in the presence of the oxidizing agent
by MTT assay, Vybrant® MTT Cell Proliferation Assay Kit (M6494) was ordered from
ThermoFisher Scientific. Dimethyl sulfoxide (DMSO) (D2650) was ordered from Sigma
(St. Louis, MO). For flow cytometry studies, APC Annexin V (640941) was ordered from
BioLegend. Cell Staining Buffer (Cat. No. 420201) and Annexin V Binding Buffer (Cat.
No. 422201) were also procured from BioLegend, San Diego, CA. Paraquat dichloride
hydrate (36541) by Sigma (St. Louis, MO) and hydrogen peroxide (H325-100) Fisher
Scientific (Hampton, NH) were utilized to induce oxidative stress.

2.1.5 Cell Specificity and RT-PCR reagents
iTaq Universal SYBR Green RT-PCR Supermix (1725121) was ordered from BioRad. Forward and reverse primers (see Table 1).
13

2.2 Cloning of GSTM1 gene into Lenti-Plasmid
A gradient PCR was set up using Phusion flash high Fidelity PCR mix for eight
different temperatures using the Primers (Table 1). The primers were generated using
NCBI Primer Blast software and were ordered from Integrated DNA technologies. The
lyophilized primers were reconstituted in a premade TAE (Tris-acetate-EDTA) buffer
already made in the lab. The template of pUC-GSTM-1 was amplified by a gradient
PCR using Phusion Flash High Fidelity PCR Mastermix and the bands were excised
and gel eluted using PureLink Quick Gel Extraction kit. The concentration and purity of
the eluded Template were determined by using a Nanodrop spectrophotometer.
Restriction digestion was set up using Fast digest enzymes EcoR I and Not I for 15
minutes at 37 oC followed by a heat inactivation for five minutes at 80 oC. A similar
procedure was followed for pCDH vector backbone already present in the lab, with
EcoR1 and Not1. The top band from the vector (7072 bp) and a single insert (682 bp)
were excised and gel eluted using Manufacture's protocol provided with Invitrogen
PureLink Quick Gel Extraction kit. Both the insert and the vector were quantified by
Nanodrop. Briefly, set the heat block to 50 oC. Excise the minimum area from the gel
containing the DNA fragment using UV light. Avoid excess exposure to UV light as it
can result in DNA degradation and damage. Weigh the gel and tare with the weight of
the empty microcentrifuge tube. Depending upon the weight add the Gel Solubilization
buffer and place on the heat block for 10 minutes at 50 oC performing periodic
inversions of the tube. After the gel appears to be dissolved incubate for additional 5
minutes. Add one volume of isopropanol to the dissolved gel. Load the dissolved gel
into the Quick Gel Extraction column inside a wash tube and spin the column at 14,000
14

g for one minute. Discard the flow-through and add 500 μl of wash buffer containing
ethanol to the column and centrifuge at 14,000 g for one minute and discard the flowthrough. Centrifuge the column at 16,000 g for two minutes and discard the flow-through
to remove ethanol completely. Add 20 μl of water and incubate for two minutes at room
temperature and centrifuge at 14,000 g for one minute. The elution tube contains the
purified DNA which can be stored at -20 oC until further use.
The ligation reaction was set up using the T4 DNA Ligase. NEBiocalculator was used to
set up three ligation ratios (3:1, 7:1, 10:1). The vector mass of 30 ng was utilized. The
ligation mixture was kept at room temperature for one hour. DH5α cells were
transformed with 3 μl of ligation mixture along with 1 μl of control plasmid. Then plated
on an LB Agar plate containing 0.1% ampicillin, incubated at 37 oC overnight. The next
day, single colonies were obtained in 3:1 and 10:1 ratio. Chosen colonies were cultured
in 10 ml of LB media containing 0.1% ampicillin overnight at 37 oC. The amplified
plasmids were then extracted from the cultures by miniprep kit and following the
manufacturer's protocol. The concentration and purity were assessed by using the
Nanodrop instrument. To validate the cloned plasmid another restriction digestion was
performed using Fast digest XBA I and NOT I. The right clone released bands at 7060
bp and 694 bp, which were chosen for Maxiprep. The maxiprep product was tested by
XBA I and NOT I.

2.3 Lentivirus production
HEK293 cells were seeded at a seeding density of 3 x 106 cells per well in 10 ml
of DMEM media with FBS and without penicillin/streptomycin blend. For cell seeding, a
15

10 cm diameter tissue culture treated plate was utilized. After 24 hours of seeding, the
DMEM media was replaced with 10 ml of Opti-MEM one hour before transfection. The
cells were co-transfected with pRSV-Rev, pMDL, pMD2 viral packaging plasmids
already present in the lab along with the newly synthesized Lenti-Gstm-1 plasmid. The
DNA: PEI ratio was selected to be 1:3. Each plasmid was quantified and 4ug per
plasmid was added to 5 ml of Opti-MEM for overnight transfection. After 12-18 hours
post transfection, a media change with DMEM with FBS and without
penicillin/streptomycin was carried out. The lentivirus was harvested after 72 hours
post-transfection. After 72 hours, the DMEM media containing virus was collected and 2
ml of PEG-itTM Virus Precipitation Solution (5x) was added to 8 ml of media and kept at
4 oC overnight for virus concentration. The next day, the concentrated virus was
pelleted by spinning at 2500 g for 30 minutes. Once the pellet is obtained, resuspend
the pellet in 100 μl of 1X PBS under the cell culture hood and store at -80 oC until
further use.

2.4 Retroviral transduction of Lentivirus for Stable cell Line generation
One hour before transfection with lentivirus change the media to Opti-MEM. In a
6-well slide, plate 75,000 cells per well in 750 μl of media and simultaneously add
diluted 5 μl lentivirus in 745 μl in DMEM-F12 media containing 10 μg per ml of
polybrene without antibiotic. Repeat the same procedure with 10 μl of lentivirus in the
740 μl of DMEM-F12 media containing polybrene without antibiotic. Remove the
transfection media after 24 hours of transfection and change with DMEM-F12 media
with polybrene. After 72 hours of transfection, add the media containing 2μg/ml and 10
16

μg/ml of Puromycin for stable cell selection. Perform media changes every day till cells
are fully confluent. Capture cell images to monitor the health of cells by comparing with
control cells without virus and cells treated with puromycin. After the 6-wells are 60%70% confluent, transfer the cells to a 10 cm tissue culture plate for expansion.

2.5 Protein Extraction and Protein Quantification
For protein extraction, the 6-well plate was placed on ice and each well was
washed with PBS. The cells were scraped by the addition of 160 μl of RIPA: PI (100:1)
on ice. The cell suspension was transferred to a 1.5 ml microcentrifuge tube and
centrifuged at 15,000 RPM for 30 minutes at 4 oC. The supernatant was carefully
removed leaving behind the cell pellet. For protein quantification, standards were
prepared by using Albumin. The standards were vortexed (30 seconds) then incubated
on ice for a total of three times. In a 96-well plate, 10 μl of standards and samples were
added in duplicates. Then 150 μl of Pierce 660 nm Protein Assay Reagent was added
and the plate was placed on the shaker for 5 minutes at room temperature. The proteins
were quantified using BioTek Gen5 Data Analysis software.

2.6 Western Blotting
For western blots, 15-20 μg of protein with one-third of the Licor's 4X loading
buffer + 10% BME was calculated. The mix was denatured at 95 oC for 5 minutes and
then loaded in the Invitrogen's Bolt Mini Gel tank precast gels cassettes. The gel was
run at 20 mA for one hour than at 35-40 mA till completely resolved. The cassette was
removed, and the gel was transferred to a Nitrocellulose membrane using the iBlot 617

minute transfer protocol. The membrane was blocked overnight at 4 oC with the
Odyssey Blocking Buffer using gentle shaking. The next day, four five-minute washes
with PBS + 0.1% Tween were carried out and the primary antibodies were added which
were diluted in Odyssey Blocking Buffer and incubated at room temperature at 37 oC for
4 hours with gentle shaking. The following step was to perform four washes with PBS +
0.1% Tween. The secondary antibodies were diluted with PBS + 0.1% Tween and
incubated at room temperature for 45 minutes with constant shaking and in dark. After
the incubation period, four washes with PBS + 0.1% Tween were conducted by gentle
shaking. The membrane was visualized using Licor's Odyssey CLx instrument.

2.7 MTT Assay
Cells were seeded in complete media in a 96 well plate at a density of 6000
cells/well and were incubated at 37 oC for forty-eight hours after plating. The media was
replaced with 150 μl of DMEM-F12 serum-free and phenol-red free media containing
100, 200, 300, 400, 500 μM of H2O2 for 1 hr. Later the media was replaced with 5mg of
MTT which was dissolved in 1 ml of PBS and diluted with 9ml DMEM-F12 serum-free
and phenol-red free media. Post three hours, the MTT solution was aspirated and
replaced with 100 μl of DMSO to solubilize the blue formazan crystals. Readings were
measured after 10 minutes at 540 nm wavelength using BioTek Gen5 Data Analysis
software through BioTek’s Synergy Neo2 hybrid multi-mode plate reader by Life
Sciences.
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2.8 Flow cytometry
For flow cytometry, cells were seeded in complete media in a 6 well plate at a
density of 150,000 cells/well and were incubated at 37 oC for forty-eight hours after
plating. The media was replaced with 2 ml of DMEM-F12 serum-free and phenol-red
free media containing 500 μM of H2O2 for 3 hr. Later the media was collected, and cells
were removed by trypsinization. The cells were washed with 1 ml of cell staining buffer
and to obtain the pellet. The pellet was resuspended with 100 μl of cell binding buffer
and 5 μl of Annexin V was added. After 20 minutes, 5 μl of DAPI was added and
samples were analyzed by BD Sciences FACSCanto counting 3000 cells per reading.

2.8 Immunocytochemistry
Prepare the cell culture slides by removing the media and wash two times with
PBS. Fix the slides with four percent of paraformaldehyde in PBS for 15 minutes at
room temperature. Aspirate and rinse with PBS three times, each was lasting for 4
minutes. Then permeabilized the samples with 1% of Triton for 10 minutes. Aspirate the
Triton and rinse two times with PBS. Incubates the samples with 5% of normal good
serum in PBS at room temperature for 30 minutes. Aspirate the goat serum and add
primary antibody diluted in PBS. Keep it overnight at 4 oC rinse with constant shaking.
Wash with PBS three times and incubate the samples with the secondary antibody for
45 minutes at room temperature. Add DAPI and keep for 10-15 minutes. Rinse with
PBS after taking out from the chamber to add Fluromount just amount enough to cover
the coverslip and image the slides using Keyence BZ-X800 all in one fluorescence
microscope by KEYANCE, America.
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2.9 RT-PCR
Total RNA was extracted from the transfected cells and non-transfected groups
treated with an oxidative stressor (H2O2). The total concentration of the RNA was
analyzed using a NanoDrop spectrophotometer, Thermo Scientific and 1000 ng of RNA
was used for cDNA synthesis. Master mix was prepared using iTaq SYBR green
supermix and respective primers (Table 1). Samples were analyzed in quadruplicate
and the reaction was set using the manufacture’s protocol given by BIO-RAD. Briefly, 5
μl of iTaq universal SYBR green Supermix was mixed with 0.5 μl of forward and reverse
primer each and 3 μl of water and 1 μl of individual cDNA was used per PCR reaction.
The PCR cycle was set for Polymerase Activation and DNA denaturation at 95 oC for 20
to 30 seconds then denaturation at 95 oC for five seconds and annealing at 60 oC for 30
seconds was carried out for 38 cycles using Bio-Rad CFX96 Touch™ Real-Time PCR
Detection System.

2.10 Statistical analysis.
Statistical analysis was performed using the Prism 9 software (GraphPad, San Diego,
CA). Statistical significance was reported whenever the calculated P value was ≤ 0.05.
*P-value ≤ 0.05, **P-value ≤ 0.01, ***P-value ≤ 0.001.

20

CHAPTER THREE:
RESULTS
3.1. Cloning of pUC-GSTM-1 in Lentivirus vector backbone
3.1.1 PCR amplification
As shown in (Figure 3), the pUC-GSTM-1 plasmid was used to amplify the
specific region containing GSTM-1 insert by the designed forward and reverse primers
(Table 1). The Gradient PCR at eight different temperatures (69.0, 68.5, 67.5, 66.0,
64.2, 62.7, 61.6, 61.0) resulted in successful amplification of the desired genomic
sequence. As amplification was observed in the selected temperature range, the gel
was excised and eluted to obtain a GSTM-1 insert.

69

68.5, 67.5

66

64.2

62.7 61.6 61

Figure 3. Gradient PCR for pUC-GSTM-1 insert by using forward and reverse
primers, then run on 1.5% agarose gel for 40 minutes at 130 V.
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3.1.2. Restriction digestion of GSTM-1 insert and Lentivirus plasmid
backbone
The insert for Lenti-GSTM-1 was processed by performing a restriction digestion
on the obtained Gradient PCR product with EcoRI and NotI which yields a band at 682
bp, (Figure 4). On gel elution and quantification of the eluted product, the concentration
of the insert was 39.4 ng/ μl with an A260/A280 value of 1.85. The lenti-virus plasmid
backbone was obtained from pCDH-EF1-TGFB1-T2A-Puro (available in Biswal lab) by
performing a restriction digestion with EcoRI and NotI. The top band at 7072 bp was gel
eluted and quantified (Figure 5). Due to the generation of the sticky ends the hGSTM-1
insert was successfully ligated into plasmid backbone.

Figure 4. Restriction enzyme digestion of Gradient PCR product with EcoRI and
NotI to obtain insert, then run on 1.5% agarose gel for 40 mins at 130 V.

22

Figure 5. Restriction enzyme digestion of pCDH-EF1-TGFB1-T2A-Puro with EcoRI
and NotI to obtain plasmid backbone, run on 1.5% agarose gel for 40 mins at 130V.

3.1.3. Confirmation of positive clones of Lenti-GSTM-1
The ligation reaction was set up for three different vector: insert ratios (1:3,
1:7,1:10). The DH5- alpha cells were transformed and colonies were harvested. The
right clones resulted in bands at 7060 bp and 682 bp, upon restriction enzyme digestion
with XbaI and NotI (Figure 6). Only the positive clones were further processed for
lentivirus production. In Figure 4, only clones 4 and 5 resulted in correct band release
upon restriction enzyme digestion and were further processed to isolate high-quality
plasmid DNA by Maxiprep.
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Figure 6. Restriction enzyme digestion of Lenti-GSTM-1-T2A-Puro plasmid with
EcoRI and NotI and run on 1.5% agarose gel for 40 mins at 130V. The clone 4
and clone 5 were positive for Lenti-GSTM-1.

3.2. Production of Stable cell expressing Lenti-GSTM1
3.2.1. Lentivirus production.
On reaching a 90% confluency of HEK-293T cells (passage 13) in a 10 cm tissue
culture plate, a co-transfection was carried out with viral packaging plasmids; pMDL,
pRSV-Rev, pMD2 and Lenti-GSTM-1 plasmid or control GFP plasmid. After 48 hours
post-transfection, transfection efficiency was determined by observing the fluorescence
intensity from the GFP control plasmid (Figure 7 A. and 7 B). Lentivirus was harvested
from the media after 72 hours.
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A

B

Figure 7 A. HEK-293 cells after 24 hours post seeding B. HEK-293 cells post
transfection with control GFP plasmid. The DNA to PEI ratio used was 3:1.
Observed at 4x magnification after 48 hours post transfection.

3.2.2 Stable ARPE-19 cell selection.
The cells were treated with polybrene (10 mg/ml) and 5 μl and 10 μl of virus for
24 hours before the first media change. Stable ARPE-19 cell transfectants were
selected after 72 hours after the cells were treated with 2 μg and 10 μg of Puromycin.
The stable cell selection process takes 7-10 days (Figure 8). Due to the presence of the
puromycin-resistant gene in the vector backbone, cells infected with the virus will
demonstrate resistance to the puromycin treatment. The cells were selected till 100%
cell death was observed in the controls.
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A

B

C

D

E

F

Figure 8. Demonstrates growth of A. control cells, B. control cells treated with 10
μg puromycin, C. control cells with 5 μl of lentivirus and 10 μg of puromycin
observed at 4x magnification after 10 days post seeding. D. control cells, e.
control cells treated with 10 μg puromycin, f. control cells with 5 μl of lentivirus and
10 μg of puromycin observed at 10x magnification, after 10 days post seeding.

Among the 2 μg and 10 μg puromycin concentration, 10 μg of puromycin demonstrated
effective cell death as compared to 2 μg of puromycin, thus these stable cells were
selected for further processing, Figure 9 A and B.
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A

B

Figure 9. Demonstrates growth of cells treated with A. 2 μg and B. 10 μg of
puromycin after 10 days post seeding, observed at 4x magnification.

3.3. Western Blotting
The western blotting confirmed the expression of hGSTM-1 in the stably
transfected ARPE-19 cells. The western blot also verified that the hGSTM1 was of the
correct molecular size (26 kDa) also the Tubulin (55 kDa) (Figure 10 A). The cell
specificity of ARPE-19 was tested antibodies against RPE-specific gene RPE65 which
participates in visual cycle and antibodies against P2A confirms the exogenous
expression of hGSTM-1 (Figure 10 B). This analysis of cellular protein extracts
confirmed that the transfection by the lenti-GSTM-1 was successful resulting in the
expression of GSTM1 protein.
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Figure 10 A. Expression of antibodies against GSTM1 (green) and tubulin (red) B.
Expression of antibodies to evaluate presence of RPE (green) and P2A tag (red).
Duplicates of Lenti-GSTM-1-T2A, No transfection (NT) controls, positive control,
No transfection control.

3.4 Cell viability by MTT assay and Flow cytometry
To evaluate the benefits of GSTM1 gene augmentation, stably transfected cells
were challenged with H2O2 treatment. Although the controls or non-transfected cells
demonstrated a dose-dependent decrease in the cell viability, stably transfected
hGSTM1 cells demonstrated a significant increase in cell viability in response to 200,
300, 400, 500 μM of H2O2 treatment for one hour (Figure 11 A). Flow cytometry was
carried out by selecting single concentration (500 μM) of H2O2. In agreement with the
MTT assay findings, flow cytometry on the hGSTM-1 transfected cells also indicated
significant protection compared to the controls (Figure 11 B).
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A. MTT ASSAY

B. FLOW CYTOMETRY

Figure 11. A. MTT assay showing cell viability of lenti-GSTM1 transfected cells
against H2O2-induced oxidative stress. Significant protection(p<0.05) was
observed when cells were treated with 200 μM and 500 μM H2O2.
B. Flow cytometry demonstrated significant increase (P<0.5) in cell viability as
compared to the non-transfected cells.
29

3.5 Immunocytochemistry
As oxidative stress causes a major disruption in the RPE junctional integrity, presence
of exogenous GSTM-1 restored cellular integrity impaired by oxidative stress. The lentiGSTM-1 transfected cells did not demonstrate inherent disruption in differentiation cells.
The cells were differentiated by using MEM-NIC media for 3-week duration. The media
was replaced alternatively to avoid any contamination in the cell culture system. The
stable cell lines demonstrate mitochondrial protection, which was confirmed by TOM20
staining a major receptor in the mitochondrial preprotein translocation system (Figure
12). In the presence of gene augmentation, the cellular integrity is improvised as
compared to the non-transfected cell lines (Figure 13).

A

B

C

Figure 12. In the presence of oxidative stress induced by Paraquat (1000 μM) for
24 hours, mitochondrial morphology and function was considerably maintained in
the stably transfected and differentiated cells verses controls confirmed with
TOM20 staining. A. Control cells B. Control cells treated with paraquat (1000 μM),
C. Lenti-GSTM1 stable cells with paraquat (1000 μM). (Red: TOM20, Blue: DAPI
n=3)
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B

C

D

Figure 13. The stably transfected hGSTM-1 differentiated cells protects against
the loss of tight junctions caused by oxidative stress
A. Control cells, B. Control cells treated with paraquat (1000 μM), C. Lenti-GSTM1
stable cells, D. Lenti-GSTM1 stable cells with paraquat (1000 μM) for 24 hours.

3.6 Cell specificity and RT-PCR analysis
The cell specificity assay confirmed native RPE characteristics were maintained by
ARPE-19 cell cultures as they were cultured and passaged several times. The
expression of ARPE-signature genes was confirmed with occludin (OCLN), protein
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encoding for the tight junction in the RPE cells, MERTK and integrin β5 (ITGB5),
involved in phagocytosis of photoreceptor outer segments (POS) (Figure 14).

Figure 14. Demonstrates the expression of RPE-signature genes. C is the control
cells and S indicates stably transfected cells.

On RT-PCR analysis the gene expression changes were monitored. Significant
changes were not observed which can be attributed to the duration of the treatment and
the dose of the oxidant. However, the expression of proinflammatory cytokines was
impacted. A significant decrease in the Interleukin-1β (IL-1β) was observed in contrast
to this the expression of other proinflammatory cytokines remained ambiguous (Figure
15). As proinflammatory cytokines are released in the media, an ELISA should be
performed to evaluate the true levels of proinflammatory cytokines.
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Figure 15. The stably transfected hGSTM-1 cells reduced proinflammatory responses
as compared to the control cells under oxidative stress. Transcript levels relative to
GAPDH control were set. Values are presented as mean ± SD (n=3) **P<0.05.
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CHAPTER FOUR:
DISCUSSION
The present study is parallel with the findings in the literature. It is an established fact
that reactive oxygen species (ROS) are continuously generated in RPE cells due to
reduction of oxygen, inherent phagocytic processes, and metabolism of xenobiotics.
These generated ROS are responsible for facilitating lipid peroxidation. The cumulative
effect of this process results in the formation of phospholipid hydroperoxides which
eventually breakdown to form toxic malondialdehyde (MDA) and 4-hydroxynonenal (4HNE). The toxic aldehydes act as reactive secondary messengers further augmenting
the initial free radical event (Esterbauer et al., 1991). Other implications of ROS involve
damage to mitochondrial DNA (mtDNA) and disruption to electron transport chain (ETS)
(Ahmad & Ahsan, 2020). Several ophthalmic diseases like retinopathy, cataract and
age-related macular degeneration are implications of lipid peroxidation (Phaniendra et
al., 2015). The role of α-GSTs isoforms to ameliorate the effects of oxidative stress has
been studied. The research has demonstrated the role of GSTA1-1, a major α isoform
of GST family to protect RPE cells from oxidative damage. The transfected hGSTA1-1
when subjected to oxidative stress-induced due to hydrogen peroxide demonstrated
greater cell viability and decreased lesion frequency an indication of reduced mtDNA
damage (Liang et al., 2005). Also, hGSTA1-1 protected against the oxidative damage
caused by naphthalene-induced lipid peroxidation in human lens epithelial cells (Yang
et al., 2002). Lipid peroxidation products (LPO) have a strong indication in the
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pathogenesis of AMD. The levels of LPO were dramatically increased in the posterior
pole retina in contrast to peripheral retina in the AMD patients (De La Paz & Anderson,
1992). Hence if we could move the needle of research in order to enhance the cellular
defense against the LPO, it can serve as a pivotal strategy to be employed in the
geographic AMD treatment. A brief analysis of the ongoing clinical trials demonstrated
the use of AAV-mediated gene therapy and advent of anti-vascular endothelial growth
factor treatments with ranibizumab port delivery system and faricimab for neovascular
AMD. Yet the potential treatment option for geographic AMD remains elusive and by far
a clinical trial involving intravitreal AAVCAGsCD59 verses the sham injection is in
progress (Biosciences). Our data collectively establishes a foundation demonstrating
that induction of GSTs in RPE cells in presence of oxidizing agents can protect against
the oxidative stress and aid to improve AMD pathology. The exact and the detailed
mechanism of GSTs conferring protection is yet to be discovered, but literature purports
that GSTs protect the RPE cells through there GPx activity towards the formed LPO
(Zhao et al., 1999). Thus, we hypothesized that RPE cells exposed to oxidative agents
like hydrogen peroxide and paraquat leads to generation and activation of LPO cascade
reactions which ultimately leads to damage the cellular integrity and mitochondrial DNA
leading to a decrease in cell viability. To counter this, overexpression of GSTM-1
isoform in RPE cell can lead to detoxification of LPO and does effectively reducing the
cell death by improving the cellular integrity and mitochondrial function. Based on the
results of MTT assay and flow cytometry it demonstrates that GSTM-1 transfected RPE
cells express significant protection against the oxidative stress induced by hydrogen
peroxide. Our data is consistent with the literature that demonstrated the protective
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effect against the oxidative stress due to the upregulation of GSTs. The build-up of ROS
lead to a significant damage in the cellular integrity and the mitochondrial function of the
RPE cells can be countered with GSTM-1 treatment (Cai et al., 1999). The disrupted
mitochondria not only are less effective as the cells powerhouse but also are associated
with increasing the production of ROS which can facilitate further damage to the RPE
cells (Cai et al., 1999). Based on our results, the up regulation of GSTM-1 gene can
protect the cells from the loss of the mitochondrial function. The transepithelial barrier
function is maintained if the tight junctions (TJs) between the cells are secured. The
presence of OCLN, one of the transmembrane proteins is critical and located at TJs.
The interaction of Zona occludens (ZO-1) protein with the intracellular domain of OCLN
dictates healthy physiology of RPE (Rao et al., 2002). The alterations in the paracellular
junctional complexes are prominent under oxidative stress which were mitigated in the
hGSTM-1 transfected cells. However, interestingly not significant changes were
observed in the upregulation of other oxidative genes upon real time PCR analysis. This
could be attributed to the treatment time as the effect of H2O2 treatment to induce
oxidative stress is time dependent. Even though increase in the levels of catalase
(CAT), which is an important antioxidant gene in eye and Mer Tyrosine Kinase (MerTK),
implicated for macrophage survival and apoptotic cell clearance in the presence of
oxidative stress can be beneficial in AMD pathology (Anwar et al., 2009). The increase
in the proinflammatory cytokines like IL-6 and IL-17 was consistent with the previous
data studied in the supernatant of H2O2-stressed RPE cells. This can be attributed to
the activation of Nrlp3 pathway which points at inflammasome activation (Trakkides et
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al., 2019). We need to further bolster the analysis by increasing the time of oxidant as
well as selecting a suitable oxidant to induce gene transcription changes.
The advent of gene therapy in geographic AMD can fulfil the unmet needs of AMD
patients. To develop a translational treatment succeeding to achieve the approval of
FDA is filled with challenges. In the aforementioned studies we sought to initiate the
efforts for a potential treatment option. Further, we aim to translate these findings in
rodent models by using AAV-mediated or novel nanoparticle mediated gene delivery
methods.
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CHAPTER FIVE:
CONCLUSION
Age-related macular degeneration is a debilitating condition leading to a
decrease in visual acuity and causes blindness in an elderly population. This condition
has severe implications on the lifestyle of an individual and yet no cure is available in
the market. Genetic therapy opens future avenues to rectify the error of decreasing
antioxidant enzymes and can provide a potential option in AMD treatment strategies. In
this study, we establish solid in-vitro data to support further studies in-vivo in the murine
mice model for dry-AMD. It is still not clear whether GSTM-1 plays any role in the
pathogenesis of AMD even though its transcription level decreases in AMD retina. Our
study provides some crucial insights into the role of GSTM-1 to counter the ROS and
LPO formed in RPE exposed to cellular model of oxidative stress. Through our
preliminary analysis it can be concluded that in the presence of the oxidative stress
inducers, GSTM1 gene augmentation can alleviate oxidative stress-induced changes
and prevent apoptosis retinal pigment epithelial cells
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APPENDIX A:
PRIMER LIST

Table 1. List of primers for conformation of RPE specific genes by PCR analysis.
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